• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 2CT; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 2CT; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. Back to Search Results
Catalog Number 195-160
Device Problem Non Reproducible Results (4029)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/05/2023
Event Type  malfunction  
Manufacturer Narrative
D4: (b)(4).The remainder of the investigation remains in progress.A supplemental report will be provided after completion.H3 other text : other - device not returned; single use device.
 
Event Description
The consumer reported conflicting results with the binaxnow covid-19 self-test performed on (b)(6) 2023.The consumer initially tested positive with two (2) binaxnow covid-19 self-tests.The consumer performed a third test with the binaxnow covid-19 self-test generating a negative result.The consumer confirmed there was no treatment performed as a result of the test results.No additional information was provided.
 
Event Description
The consumer reported conflicting results with the binaxnow covid-19 self-test performed on (b)(6) 2023.The consumer initially tested positive with two (2) binaxnow covid-19 self-tests.The consumer performed a third test with the binaxnow covid-19 self-test generating a negative result.The consumer confirmed there was no treatment performed as a result of the test results.No additional information was provided.
 
Manufacturer Narrative
D4: (b)(4).Testing was performed at abbott diagnostics scarborough, inc.On retained kit lot 225186 with internal positive quality control samples and negative quality control swabs.All test results were valid and performed as expected.Additionally, the manufacturing records and quality control release testing was reviewed for test kit part number 195-160 / lot 225186 and device part number 195-430h / lot 220868.The lot met the required release specifications.The current overall incident rate for false positive patient results (confirmed and unconfirmed, conflicting results) for lot 225186 based on the total quantity of devices distributed is (b)(4).The current overall incident rate for false negative patient results (confirmed and unconfirmed, conflicting results) for lot 225186 based on the total quantity of devices distributed is (b)(4) in conclusion, abbott diagnostics scarborough was unable to determine the exact root cause of the reported issue, however it could have possibly been related to the specific patient sample.Other - device not returned; single use device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BINAXNOW COVID-19 AG SELF TEST 2CT
Type of Device
CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough ME 04074
Manufacturer Contact
rachel blackwell
10 southgate road
scarborough, ME 04074
6613888803
MDR Report Key17977300
MDR Text Key326193795
Report Number1221359-2023-01563
Device Sequence Number1
Product Code QKP
UDI-Device Identifier00811877011408
UDI-Public00811877011408
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EUA210264
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 11/16/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Catalogue Number195-160
Device Lot Number225186
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/10/2023
Initial Date FDA Received10/20/2023
Supplement Dates Manufacturer Received10/30/2023
Supplement Dates FDA Received11/16/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age75 YR
Patient SexMale
Patient Weight84 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-